Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 052635/0834 | |
| Pages: | 3 |
| | Recorded: | 05/12/2020 | | |
| Attorney Dkt #: | 20008-US(1)-PCT |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
2
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16302270
|
Filing Dt:
|
11/16/2018
|
|
Publication #:
|
|
Pub Dt:
|
06/13/2019
| | | | |
|
Title:
|
USE OF GLUTAMATE MODULATING AGENTS WITH IMMUNOTHERAPIES TO TREAT CANCER
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/02/2022
|
Application #:
|
16302284
|
Filing Dt:
|
11/16/2018
|
|
Publication #:
|
|
Pub Dt:
|
09/26/2019
| | | | |
|
Title:
|
USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERS
|
|
|
Assignee
|
|
|
|
|
| 234 CHURCH STREET |
| SUITE 304 |
| NEW HAVEN, CONNECTICUT 06510 |
|
|
Correspondence name and address
|
| |
DMITRY ZUEV
|
| |
215 CHURCH STREET
|
| |
NEW HAVEN, CT 06510
|
Search Results as of:
06/25/2024 04:44 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
